Stocks · News reference

Apimeds Pharmaceuticals Enters First Amendment To Settlement Agreement On Sept. 10; Board To Consist Solely Of Four Members During Interim Period; Board To Expand To Seven Members After Interim Period; Amends Settlement Agreement With Inscobee Parties

Sep 11, 2026, 1:24 PMBenzinga Newsdesk

https://www.sec.gov/ix?doc=/Archives/edgar/data/1894525/000121390026099002/ea0305245-8k_apimeds.htm

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 11, 2026, 1:10 PMSEC EDGAR
8-K filing — Apimeds Pharmaceuticals US, Inc. (APUS)
Filed: 2026-09-11 AccNo: 0001213900-26-099002 Size: 239 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
APUS
BenzingaAug 21, 2026, 9:17 PMBenzinga Newsdesk
Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On Aug 19, 2026; Freet Assigns All Apitox-Related Rights To Apimeds Pharmaceuticals; Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation For Apitox
-SEC Filing
APUS
BenzingaAug 18, 2026, 9:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came
AHG APUS CRIS HCWB IMCC